This page shows results related to Alaway and Rash from the FDA Adverse Event Reporting System (AERS). The adverse event Rash has been reported to the FDA a total of 4 times for Alaway.
Learn More About Alaway Adverse EventsThe Proportional Reporting Ratio (PRR) for Alaway and Rash is 1. The chart below compares this proportional reporting ratio of Rash for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Rash.
| Rash | |
| Alaway | 1 |
NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.
Of those reporting Rash, why were they taking Alaway?
| Drug Hypersensitivity | 1 |
| Seasonal Allergy | 1 |
| Multiple Allergies | 1 |
| Eye Pruritus | 1 |
Which medications reported to the FDA are most commonly associated with Rash?
| Humira | 4169 |
| Lamictal | 3795 |
| Nexavar | 1919 |
| Enbrel | 1896 |
| Remicade | 1693 |
| Fosamax | 1459 |
| Chantix | 1396 |
| Revlimid | 1093 |
| Vioxx | 1090 |
| Tysabri | 1080 |
| Avelox | 1017 |
 Show More |
